| Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis J Golay, L Zaffaroni, T Vaccari, M Lazzari, GM Borleri, S Bernasconi, ... Blood, The Journal of the American Society of Hematology 95 (12), 3900-3908, 2000 | 806 | 2000 |
| Pathogenesis of antiphospholipid syndrome: understanding the antibodies PL Meroni, MO Borghi, E Raschi, F Tedesco Nature Reviews Rheumatology 7 (6), 330-339, 2011 | 709 | 2011 |
| Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component B Bottazzi, V Vouret-Craviari, A Bastone, L De Gioia, C Matteucci, G Peri, ... Journal of Biological Chemistry 272 (52), 32817-32823, 1997 | 526 | 1997 |
| Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor F Fischetti, P Durigutto, V Pellis, A Debeus, P Macor, R Bulla, F Bossi, ... Blood 106 (7), 2340-2346, 2005 | 426 | 2005 |
| The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity F Tedesco, M Pausa, E Nardon, M Introna, A Mantovani, A Dobrina The Journal of experimental medicine 185 (9), 1619-1628, 1997 | 364 | 1997 |
| Inhibiting the C5–C5a receptor axis TM Woodruff, KS Nandakumar, F Tedesco Molecular immunology 48 (14), 1631-1642, 2011 | 356 | 2011 |
| Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA MA Seelen, A Roos, J Wieslander, TE Mollnes, AG Sjöholm, R Wurzner, ... Journal of immunological methods 296 (1-2), 187-198, 2005 | 348 | 2005 |
| Dynamics of complement activation in aHUS and how to monitor eculizumab therapy M Noris, M Galbusera, S Gastoldi, P Macor, F Banterla, E Bresin, ... Blood, The Journal of the American Society of Hematology 124 (11), 1715-1726, 2014 | 346 | 2014 |
| Complement in human diseases: lessons from complement deficiencies M Botto, M Kirschfink, P Macor, MC Pickering, R Würzner, F Tedesco Molecular immunology 46 (14), 2774-2783, 2009 | 331 | 2009 |
| Endothelial cell E-and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors P Lorenzon, E Vecile, E Nardon, E Ferrero, JM Harlan, F Tedesco, ... The Journal of cell biology 142 (5), 1381-1391, 1998 | 305 | 1998 |
| Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy C Carlino, H Stabile, S Morrone, R Bulla, A Soriani, C Agostinis, F Bossi, ... Blood, The Journal of the American Society of Hematology 111 (6), 3108-3115, 2008 | 286 | 2008 |
| Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis M Morigi, M Galbusera, S Gastoldi, M Locatelli, S Buelli, A Pezzotta, ... The Journal of Immunology 187 (1), 172-180, 2011 | 285 | 2011 |
| Complement activation in patients with COVID-19: A novel therapeutic target M Cugno, PL Meroni, R Gualtierotti, S Griffini, E Grovetti, A Torri, ... Journal of Allergy and Clinical Immunology 146 (1), 215-217, 2020 | 273 | 2020 |
| C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation R Bulla, C Tripodo, D Rami, GS Ling, C Agostinis, C Guarnotta, S Zorzet, ... Nature communications 7 (1), 10346, 2016 | 271 | 2016 |
| The complement system in the pathophysiology of pregnancy G Girardi, R Bulla, JE Salmon, F Tedesco Molecular immunology 43 (1-2), 68-77, 2006 | 239 | 2006 |
| C1q: A fresh look upon an old molecule NM Thielens, F Tedesco, SS Bohlson, C Gaboriaud, AJ Tenner Molecular immunology 89, 73-83, 2017 | 226 | 2017 |
| Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population M Gaya da Costa, F Poppelaars, C Van Kooten, TE Mollnes, F Tedesco, ... Frontiers in immunology 9, 2664, 2018 | 223 | 2018 |
| I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison’s disease C Betterle, M Volpato, BR Smith, J Furmaniak, S Chen, NA Greggio, ... The Journal of Clinical Endocrinology & Metabolism 82 (3), 932-938, 1997 | 194 | 1997 |
| Protection against inflammation-and autoantibody-caused fetal loss by the chemokine decoy receptor D6 Y Martinez de la Torre, C Buracchi, EM Borroni, J Dupor, R Bonecchi, ... Proceedings of the National Academy of Sciences 104 (7), 2319-2324, 2007 | 189 | 2007 |
| The membrane attack complex of complement induces caspase activation and apoptosis AJ Nauta, MR Daha, O Tijsma, B van de Water, F Tedesco, A Roos European journal of immunology 32 (3), 783-792, 2002 | 185 | 2002 |
